Scott Stromatt, EVP, Clinical Development & Reg Affair at CELL THERAPEUTICS INC (CTIC), sold 7,500 shares at $1.89 ($14K) on 2006-12-13, disclosed to the SEC on 2006-12-15.
Open-market sale of $14k CTIC by EVP, Clinical Development & Reg Affair. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.89 | 1,829 | $3K | 24.4% |
| 2 | $1.89 | 5,671 | $11K | 75.6% |
| Total | $1.89 avg | 7,500 | $14K | 100% |
| Filing → |
| CTIC | SELL | 2006-09-01 | $4K | — | Filing → |
| CTIC | SELL | 2006-06-22 | $28K | — | Filing → |